Home Accuracy in clinical chemistry – who will kiss Sleeping Beauty awake?
Article
Licensed
Unlicensed Requires Authentication

Accuracy in clinical chemistry – who will kiss Sleeping Beauty awake?

  • Linda M. Thienpont
Published/Copyright: July 2, 2008

Abstract

Triggered by recent criticism from parties outside the clinical chemistry community on poor analytical accuracy of measurement procedures used for evaluating the calcium-parathyroid hormone-vitamin D axis, I argue, in this opinion paper, strongly in favor of prioritizing the establishment of accuracy. I make a proposal on how the clinical chemistry profession could tackle the challenges focused at the conceptual, technical, and organizational level. The profession should “rehearse” the basic concepts of measurement, because they need to be understood before one can look for pragmatic solutions when a purist's approach cannot be realized in a foreseeable time. This is illustrated for the measurement of thyroid stimulating hormone (TSH). To solve problems encountered at the technical level of establishing reference measurement systems, in particular when this is not possible according to the point of view of purism, the profession should have the courage to agree on pragmatic solutions, without neglecting, however, the technical progress. This is exemplified by way of a solution for measurement of FT4 in serum water and TSH. Because the technical question is also inseparably connected to the specification of the analytical quality required for measurements, I propose that the profession sets realistic specifications for calibration tolerance, limits for batch acceptance, linearity, etc. Last but not least, I call upon organizing and implementing the accuracy process with utmost care, i.e., in a concerted action with all parties involved in patient care. The driving force towards accuracy should come from the test developers, while the lead should be taken by the clinical chemistry community, itself being guided by the clinical professions.

Clin Chem Lab Med 2008;46:1220–2.


Corresponding author: Linda M. Thienpont, Laboratory for Analytical Chemistry, Faculty of Pharmaceutical Sciences, Gent University, Harelbekestraat 72, 9000 Gent, Belgium Phone: +32-9-2648104, Fax: +32-9-2648198,

Received: 2008-3-28
Accepted: 2008-4-29
Published Online: 2008-07-02
Published in Print: 2008-09-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Review
  2. Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis
  3. Opinion Papers
  4. Local regression: a new approach for measurement system comparison analysis
  5. Accuracy in clinical chemistry – who will kiss Sleeping Beauty awake?
  6. A practical approach to instrument selection, evaluation, basic financial management and implementation in pathology and research
  7. Genetics and Molecular Diagnostics
  8. Fetal hemoglobin: assessment of glycation and acetylation status by electrospray ionization mass spectrometry
  9. Preliminary validation of real-time PCR assays for the identification of Yersinia pestis
  10. Biochemical and molecular investigation of two Korean patients with glycogen storage disease type III
  11. Are microarrays useful in the screening of ABCA4 mutations in Italian patients affected by macular degenerations?
  12. General Clinical Chemistry and Laboratory Medicine
  13. Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers – comparison of ELISA and microsphere-based multiplexed immunoassay
  14. Low serum vitamin B12 is associated with recurrent pregnancy loss in Syrian women
  15. Allantoin as a marker of oxidative stress in human erythrocytes
  16. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
  17. Measurement of mycophenolic acid in plasma or serum by a commercial enzyme inhibition technique in comparison with a high performance liquid chromatography method
  18. Use of the TLX ultracentrifuge for the isolation of different density lipoproteins and effects of freeze/thawing of human plasma before ultracentrifugation
  19. Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters
  20. Reference Values and Biological Variations
  21. Reference ranges for neuroprotein S-100B: from infants to adolescents
  22. Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements
  23. Reference intervals for thyreotropin and thyroid hormones for healthy adults based on the NOBIDA material and determined using a Modular E170®
  24. Influence of acute physical exercise on emerging muscular biomarkers
  25. Guidelines and Recommendations
  26. Trueness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group
  27. Letters to the Editor
  28. What's in a name? Standardisation of HbA1c: a response
  29. Choice of sample for the analysis of circulating angiogenic cytokines
  30. Plasminogen activator inhibitor-1 (PAI-1), toll-like receptor 4 (TLR4), factor II (FII), FXIII and fibrinogen polymorphisms are not associated with the prevalence of sudden death due to ventricular fibrillation during myocardial infarction
  31. Spurious hypoglycemia caused by precipitation of a monoclonal immunoglobulin using the Modular P system glucose method
  32. Reporting growth hormone assay results in terms of one consensus recombinant standard preparation offers less than optimal reduction of between-method variation
  33. SI or non-SI units – which better match day-to-day imprecision?
  34. Results of hemolyzed samples can be useful
  35. Inter-laboratory survey of erythrocyte free protoporphyrin quantification – announcement of a pilot study
  36. Bacterial contamination positively interferes with β-glucosidase and hexosaminidase assays in white blood cell lysates
  37. Abstracts
  38. Congress of Clinical Chemistry and Laboratory Medicine. 5th Annual Conference of the German United Society of Clinical Chemistry and Laboratory Medicine (DGKL), September 21–24, 2008, Mannheim, Germany
  39. SIBioC 2008 40th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, October 28–31, 2008, Rimini, Italy
Downloaded on 14.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.245/html?lang=en
Scroll to top button